Nucleus vs. Herasight: Polygenic Analysis and Cost
You have several embryos, and you want to understand more before choosing which one to transfer. What are their predicted risks for diseases that run in your family? How might they differ in traits such as height or intelligence?
Nucleus and Herasight both help answer those questions through parental genetic testing and embryo analysis, with genetic counseling to walk you through the results. Both can use existing PGT-A data without another embryo biopsy, and both provide CAP-accredited, CLIA-certified laboratory testing. Nucleus is also a HIPAA-covered entity, with all customer samples processed in the United States and genetic results protected under its HIPAA privacy practices.
What the analysis costs
Nucleus Embryo costs $9,999 for up to 20 embryos, including parental testing, genetic counseling, and clinic coordination. Across the diseases and traits both services analyze, Herasight's scores perform comparably to Nucleus's.
Ask Herasight for a current quote and compare embryo limits, included parental testing, counseling, and fees across future cycles. IVF is already expensive. Nucleus was built on the belief that no intended parent should be priced out of the genetic information that could help them have a healthier baby.
What you get with Nucleus
Nucleus Embryo analyzes 38 diseases and traits, helping you explore the genetic risks that matter to your family. You can compare predicted risks for common conditions such as heart disease, diabetes, breast cancer, and Alzheimer’s, alongside traits like height, eye color, and intelligence, before choosing which embryo to transfer.
Apart from the analysis itself, Embryo includes:
Two parental Nucleus Preview whole-genome tests, screening for 2,100+ rare monogenic conditions
Genetic counseling to help you understand your results
Coordination with your clinic and PGT lab
Compatibility with donor gametes when applicable
Coverage across future IVF cycles without the need to repurchase
Nucleus Preview screens the biological parents for 2,100+ hereditary conditions, making it one of the most comprehensive carrier screening tests available for intended parents. With Preview, you can discover whether either you or your partner carries a variant associated with a rare single-gene condition, which can inform additional PGT-M embryo testing.
Once Nucleus receives your embryo data, it is combined with whole-genome data from both biological parents to calculate disease and trait scores you can compare before choosing which embryo to transfer.
Using the data that’s already available to parents, Nucleus makes advanced genetic screening more affordable, transparent, and supportive for those who want to make informed decisions about their child's health and future.
How the predictions compare
Paying more for embryo analysis does not automatically buy better predictions. Herasight’s scores are broadly comparable to Nucleus's across diseases and traits both companies analyze:
Condition | Nucleus R² | Herasight r² |
|---|---|---|
Alzheimer’s disease | 21.1% | 16.1% |
Breast cancer | 12.9% | 14.3% |
Hypertension | 15.6% | 15.6% |
Intelligence | 19.1% | 20.8% |
Multiple sclerosis | 7.1% | 7.0% |
Prostate cancer | 21.7% | 19.1% |
Type 2 diabetes | 25.4% | 22.5% |
Within-family variance explained (R²) in UK Biobank (European ancestry) for conditions both companies screen for. Disease results are on the liability scale using Nucleus’s lifetime prevalence estimates; intelligence results are adjusted for test-retest reliability.
Nucleus takes a different approach to curating the statistics used in training its scores by incorporating All of Us whole-genome sequencing-based association data into every disease score, alongside other major datasets. Nucleus also uses whole-genome sequencing data from UK Biobank, whereas Herasight uses SNP-array data from that biobank.
Additionally, Herasight draws on large published meta-analyses, where the amount and quality of data can vary across genetic variants. Those inconsistencies require additional filtering and imputation, such as filling in missing genetic information, which can reduce predictive performance.
A larger study doesn’t always produce a more predictive score. What matters is how well the model predicts risk for the condition your family cares about, including differences in risk within a family. Embryos from the same parents are siblings, which makes within-family validation particularly relevant. Nucleus publishes within-family results for every model, alongside its Origin study, which shows that its scores match or exceed published benchmarks.
Nucleus’s scores are always adjusted for your genetic ancestry, with predictive strength varying by condition and population. As such, common genetic scores from Nucleus indicate the relative increase in genetic risk compared to people of the same ancestry, and the absolute risk numbers take decreased predictiveness in non-European populations into account.
Nucleus Labs publishes population and within-family performance for the models in its initial Origin study and its entire current offering, with links to the underlying research. You can see the evidence for individual conditions rather than relying on a general claim about accuracy. Predictive strength varies by condition and ancestry, and genetic counseling is included to help parents understand their analysis as best as possible.
How Nucleus fits into your IVF process
Nucleus will never require your embryos to be transferred, nor will it ever require an unnecessary thaw and rebiopsy. Nucleus works with your existing PGT lab to obtain testing data or residual DNA, ensuring that your embryos stay frozen, and untouched, throughout the entire process.
Nucleus is designed to be straightforward from the start: purchase online, review the terms and privacy information at checkout, and the team will guide you through parental cheek swabs and coordinate access to your existing embryo data. One parent who chose Nucleus after considering Herasight described completing tens of pages of paperwork before payment or testing. Nucleus’s goal is to make it clear what you’re buying and to give you the chance to ask all your questions before any next steps, while asking only for what’s needed to complete your analysis.
Starting with Nucleus is also very flexible: you can begin before creating embryos, during IVF, or with embryos already frozen. Once you start, Nucleus manages all coordination, so you can focus on the pieces that matter: your embryo analysis and genetic counseling. The process is hands-off for both you and your clinic.
Choosing what matters for your family
Put simply, Nucleus brings together validated predictive models, genetic counseling, and clinic coordination at a price that is reflective of our goal: to help every parent have their healthiest child.
Thousands of parents have trusted Nucleus with their genetic testing and we’re happy to speak with any intended parent considering their options, and to walk through what the analysis could mean for their family.
Whether you already have embryos or are just beginning to explore IVF, book a conversation with us. We'd love to chat!




